BlackRock’s Impel Pharmaceuticals Inc. Common Stock IMPL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-22,635
| Closed | -$9.73K | – | 5376 |
|
|
2023
Q3 | $9.73K | Buy |
22,635
+5,142
| +29% | +$2.21K | ﹤0.01% | 5133 |
|
|
2023
Q2 | $22.2K | Sell |
17,493
-539
| -3% | -$685 | ﹤0.01% | 5107 |
|
|
2023
Q1 | $25.2K | Buy |
18,032
+462
| +3% | +$647 | ﹤0.01% | 5141 |
|
|
2022
Q4 | $65.9K | Sell |
17,570
-89,684
| -84% | -$336K | ﹤0.01% | 5075 |
|
|
2022
Q3 | $523K | Buy |
107,254
+9,783
| +10% | +$47.7K | ﹤0.01% | 4623 |
|
|
2022
Q2 | $908K | Sell |
97,471
-248,201
| -72% | -$2.31M | ﹤0.01% | 4485 |
|
|
2022
Q1 | $2.2M | Sell |
345,672
-9,405
| -3% | -$59.9K | ﹤0.01% | 4264 |
|
|
2021
Q4 | $3.06M | Buy |
355,077
+86,347
| +32% | +$745K | ﹤0.01% | 4149 |
|
|
2021
Q3 | $3.27M | Buy |
268,730
+17,667
| +7% | +$215K | ﹤0.01% | 4059 |
|
|
2021
Q2 | $2.22M | Buy |
+251,063
| New | +$2.22M | ﹤0.01% | 4157 |
|